Routine colchicine administration after acute myocardial infarction does not improve outcomes

The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup